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ABSTRACT
Introduction: Effective use of contraception requires women to make an informed choice about
methods that match their individual needs and expectations. The European Thinking About Needs
in Contraception (TANCO) study is a quantitative, online survey of healthcare provider and wom-
en’s views on aspects of counselling around contraception and contraceptive use.
Methods: Healthcare providers and women attending their practices for contraceptive counselling
were invited to complete online questionnaires. The women’s survey explored knowledge and use
of contraceptive methods, satisfaction with current method, and interest in receiving more informa-
tion about all methods. Healthcare provider views were gathered in parallel.
Results: A total of 676 healthcare providers and 6027 women completed the online surveys in
11 countries. There was a high prevalence of contraceptive use and general satisfaction with
current method across the countries. Fifty-five percent of women were using short-acting contra-
ception (SAC) methods; 19% were using a long-acting reversible contraception (LARC) method.
Sixty percent of women were interested in receiving more information about all methods; 73% of
women said they would consider LARC if they received more comprehensive information.
Healthcare providers tend to underestimate women’s interest in receiving information on contra-
ception in general and, more specifically, LARC methods.
Conclusions: Despite high levels of use and satisfaction with current methods, women were
interested in receiving more information about all contraceptive methods. Greater exploration of
women’s views on their needs and expectations of contraception could lead to increased know-
ledge, more effective discussions with healthcare providers and the greater likelihood of informed
contraceptive choice.
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Introduction
Today, there is a broad range of effective contraceptive
methods available. Women need access to accurate infor-
mation about these different methods to choose an option
that matches their individual needs regarding lifestyle,
family planning, risk factors and non-contraceptive benefits
[1,2]. However, to be most effective, delivery of counselling
needs to be within a patient-centred framework that
encourages discussion and shared-decision making
between a woman and her healthcare provider (HCP) [3,4].
The US Contraceptive CHOICE study in the United States
demonstrated a clear difference in uptake of long-acting
reversible contraception (LARC) methods (intrauterine
contraception [IUC] and hormonal implant) when lack of
awareness of method safety and efficacy was addressed
during a structured counselling approach and all options
were available at no cost [5,6]. Increasing knowledge and
removing financial barriers also led to greater satisfaction
and continuation with LARC methods at 12 months when
compared with the use of oral contraceptives (OC) [6].
Despite the availability of multiple, effective contracep-
tive methods, there remains a high rate of unintended
pregnancies globally [7], with significant social and
economic consequences [8,9]. Improved access to LARC
methods in the US Contraceptive CHOICE study reduced
the incidence of teenage pregnancy and birth and abortion
rates when compared with national rates among sexually
experienced teens and led to cost savings within the US
healthcare system [10]. In an effort to increase the use of
more effective, user-independent methods, there has been
a paradigm shift in recommendations regarding the coun-
selling of young women on the use of LARCs. Guidance on
best practice from global and national organizations is
focused on broadening access to LARC methods by
attempting to remove barriers relating to age, parity and
risk of sexually transmitted infections [11–14]. Despite these
recommendations, lack of knowledge of LARCs and misper-
ceptions around efficacy and side effects continue to limit
women’s choice of these highly effective methods [15,16].
Furthermore, discussion of LARCs may be limited by HCP
assumptions about women’s interests and beliefs when
choosing a method of contraception [15,17,18]. Healthcare
providers continue to be the most trusted source of sexual
health information and therefore hold a key position in the
delivery of reliable facts about contraception, despite a glo-
bal increase in use of the internet and social media [19]. In
addition, limitations around reimbursement for counselling
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itself may represent a barrier in HCP provision of counsel-
ling on all methods. The initial Thinking About Needs in
Contraception (TANCO) study, conducted in Germany, pro-
vided country-specific insights into the extent to which
women’s choice of contraceptive method depends on their
gynaecologist’s advice and whether broader counselling,
which includes all methods, could increase interest in use
of LARC methods [18]. In this survey, only 9% of the 18,521
women were using LARC methods, yet 60% of the women
stated they would consider LARCs as an option if they were
provided with more information. Gynaecologists underesti-
mated this high-level interest, believing that only 18% of
women would be interested in LARC methods.
The European TANCO study was initiated in February
2017, with the specific aim of assessing multiple aspects of
contraceptive use by women in 11 countries. Healthcare
provider insights were gathered in parallel to provide add-
itional guidance on how to better address current unmet
needs in contraceptive counselling. This publication
describes the final results of the European TANCO study.
Objectives
The primary objectives of the TANCO European study
were to:
 Evaluate women’s use, awareness and self-reported
knowledge of contraception;
 Assess satisfaction with current methods, including com-
pliance with OC;
 Identify women’s needs and expectations of contracep-
tion and measure their interest in receiving regular or
more extensive information about all methods;
 Compare the insights into women’s needs and expecta-
tions with what HCPs perceive to be women’s priorities
when choosing a contraceptive method.
The study also evaluated perception of HCP contracep-
tive counselling services from both the practitioner and
patient perspective.
Materials and methods
The European TANCO study was a quantitative online survey
of HCP and women’s views on aspects of counselling around
contraception and contraceptive use. The study concept was
designed jointly by a global market research organisation
(Psyma Health and Care) and the sponsor, Bayer AG. The
European Society of Contraception (ESC) supported the
study by facilitating access to HCPs in target countries.
Healthcare providers with at least two years’ experience
of clinical practice and providing regular contraceptive
counselling services were recruited on a country by country
basis from Belgium, Czech Republic, Finland, France,
Ireland, Poland, Portugal, Slovenia, Spain, Sweden and
Switzerland via existing local market research databases in
the respective countries and included gynaecologists, gen-
eral practitioners, nurses and midwives. Women were
invited to participate via the individual HCP practices.
Written information containing a description of the study
and instructions on how to access the online questionnaire
was handed to women attending for contraceptive counsel-
ling and/or women’s healthcare services. Women were then
free to choose whether to participate. To be eligible,
women had to be aged between 18 and 49 years.
The study involved completion of online questionnaires,
the starting point for which was a 45-item survey devel-
oped by contraception experts in Germany for use within
the German TANCO study described by Oppelt et al. [18]
Questions for the European TANCO study were extracted,
modified, and evaluated for scientific quality, clarity and
relevance to an international population by the authors. An
overview of the question topics is included in Figure 1. The
final questionnaires comprised 18 questions for women
and 17 questions for HCPs and were designed to be com-
pleted in 10 and 15min, respectively. Both were tested for
clarity, ease of completion and accuracy regarding the time
needed for completion amongst HCPs and women in one
pilot country (Ireland) prior to translation and roll-out to
the remaining countries. Some questions were slightly
modified during the roll-out process to meet regulatory
requirements and product availability in specific markets
for example, exclusion of brand names was required in
some countries and the hormonal implant was not avail-
able in Slovenia. Women not meeting the age criteria were
automatically excluded from the study by a screening ques-
tion. Initial questions for women focused on demographic
data: life situation relative to job, partnership status, and
family planning. They were then asked questions about
their awareness, self-reported knowledge and use of differ-
ent contraceptive methods. Women were asked to select
one of the following four options: ‘know very well (what it
is and how it works)’; ‘know some basic information’; ‘only
heard of it before’; or ‘have not heard of it at all’ in
response to the question ‘How well do you know… the 14
contraceptive methods’ (listed as combined pill, mini-pill
[progestogen-only pill, POP], contraceptive ring, contracep-
tive patch, contraceptive injection, contraceptive implant,
hormonal coil [IUS], copper coil [IUD], contraceptive cap,
spermicide, natural methods, condom, morning after pill,
and sterilisation/vasectomy). Women were asked to select
their current method of contraception from an identical list.
Satisfaction with current contraceptive method and
important needs and expectations around contraception
were assessed using a seven-point scale (1–7, where
1¼not satisfied/not important and 7¼ very satisfied/very
important depending on the question). Comparison of
overall satisfaction and importance was carried out using
the proportion of respondents selecting the top two
answers (i.e. a score of 6 or 7) to these questions plus the
mean value (1–7). Women’s interest in receiving more fre-
quent or additional information regarding all methods of
contraception was assessed by asking women to choose
from one of four responses: ‘yes, more frequent especially
for new products’; ‘yes, more extensive’; ‘yes, more frequent
and more extensive’; or ‘no, I do not need any additional
information’. Additional questions regarding use of contra-
ception focused on the frequency with which women for-
got to take their OC and their use of emergency
contraception. The final section of the questionnaire
assessed women’s views on the contraceptive counselling
services provided by their HCP, including amount of infor-
mation shared, time taken to counsel, friendliness and ease
of getting an appointment, using a seven-point scale (1–7,
where 1¼unsatisfactory and 7¼ very satisfactory). Results
are reported in the manner described above.
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Healthcare providers completed 17 questions in total.
Early questions gathered information on professional
experience, place of work, number of women treated per
quarter, common contraceptive methods prescribed and
experience with placement of IUC devices and facilitated
the filtering of those HCPs not meeting the study inclusion
criteria in terms of duration of clinical practice. The remain-
ing questions and response scales mirrored those asked of
the women in order to determine HCP perceptions of
women’s use of and attitudes towards contraception, their
compliance and their views on the services HCPs provided.
The study took place between February and November
2017. Survey design, distribution logistics and administra-
tion were coordinated by Psyma Health and Care and
funded by the sponsor, Bayer AG. International review
board (IRB) approval was not sought as patient response
data would be anonymized, aggregated as global data for
the purposes of analysis and reporting and not retained by
the market research agency. Statistical analyses of descrip-
tive and comparative data (i.e., comparison of demographic,
country, and method use) was carried out by Psyma using
SPSS. Participating HCPs received monetary and non-
monetary incentives equal to their dedicated time and in
accordance with local market research guidelines. The latter
involved the offer of individual practice data (provided at
least n¼ 10 of their own patients completed the survey) or
an analysis of the regional data. In all cases, the data
included in these reports was numeric only.
Results
From February to November 2017, a total of 1049 health-
care providers and 7483 women in 11 European countries
accessed the respective online surveys. Sixty-five percent
(n¼ 676) of HCPs and 81% (n¼ 6027) of women accessing
the survey went on to complete the respective question-
naires (see Table 1). Of the 676 HCPs participating in the
study, 87% were gynaecologists, 8% were GPs and 5%
were nurses or midwives. Sixty-three percent were female.
Thirty-nine percent of HCPs worked only in private practice;
13% worked only in hospitals; and 34% worked in both
hospital and private practice. On average, HCPs had 20
years of working experience and saw 140 patients aged
Table 1. Number of women and HCPs who com-
pleted the respective online surveys by country.
Surveys completed:
By women By HCPs
Belgium 15 2
Czech Republic 230 11
Finland 116 18
France 785 118
Ireland 180 22
Poland 1083 100
Portugal 1223 100
Slovenia 311 30
Spain 1600 213
Sweden 239 26
Switzerland 245 36
Figure 1. Question topics included in the European TANCO survey.
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between 18 and 49 years per month for contraceptive
counselling. Ninety-two percent of HCPs were currently
placing IUC devices; on average, they inserted three to four
IUC devices per month (range 1–8 per month).
Of the 6027 women participating in the study, the aver-
age age was 32 years; 73% were married or in a stable rela-
tionship and 67% were employed (either full- or part-time).
Almost half of women (45%) were parous, with an average
of two children. Seventy-two percent of women were not
planning to have any children in the next three to
five years.
Awareness and self-reported knowledge of currently
available contraceptive methods
When asked about their awareness of currently available
contraceptive methods, only 17% of women reported good
or basic knowledge of all 14 methods presented. On aver-
age, women knew very well or had a basic knowledge of
nine methods. Women’s self-reported knowledge of com-
bined pills, mini-pills, natural methods and emergency
contraception was highest: 88%, 77%, 83%, and 84% of
women respectively rated their knowledge of these meth-
ods as good or basic (see Figure 2). Women’s knowledge of
the hormonal IUS, copper IUD, vaginal ring and hormonal
patch was not as extensive: 71%, 67%, 64%, and 64% of
women, respectively rated their knowledge of these meth-
ods as good or basic. Overall, self-reported knowledge of
IUC (hormonal IUS and copper IUD) was significantly lower
than for OCs (combined pill and mini-pill); 69% and 83%,
respectively. Notably, significantly older women (aged
40–49 years) reported good or basic knowledge of IUC
when compared with those aged 18–29 years (46% versus
27%). Levels of self-reported knowledge of different meth-
ods in individual countries were generally consistent with
overall findings.
Contraceptive use by women
Ninety percent (n¼ 5448) of the women surveyed
stated that they were currently using contraception (see
Figure 3(a)). More than half (55%) were using a short-acting
contraception (SAC) method: 34% were using a combined
pill and 15% were using a mini-pill. Eighteen percent of
women were using a LARC method: 9% hormonal IUS; 6%
copper IUD and 3% hormonal implant. Almost one-third
(29%) of women were using the condom, of which 12%
were using it as their sole method. There was greater use
of SAC methods than LARC methods by women in all coun-
tries (see Figure 3(b)). Use of SAC methods ranged from
43% (Finland) to 79% (Belgium/Czech Republic); LARC use
ranged from 7% (Portugal) to 38% (France).
Healthcare providers also estimated combined pills to
be the most frequently used method by patients (46%).
When looking at the impact of age, marital status and par-
ity on contraceptive use, women using SACs (n¼ 3315)
were generally younger (mean age 30 years) than those
using LARCs and nulliparous. The mean age of women
using LARCs (n¼ 1057) was 36 years and they were gener-
ally married, or in a stable relationship, and parous.
Satisfaction: the extent to which women feel happy
with current method
Overall satisfaction with current contraceptive method was
high; more than 50% of women indicated they were highly
satisfied (i.e., rated as 6 or 7 on scale of 1–7) (see Figure 4).
When looking at the three most commonly used prescrip-
tion methods (combined pill, mini pill and hormonal IUS),
satisfaction was significantly greater amongst users of the
hormonal IUS: 78% indicated high satisfaction with this
method compared to 71% for the combined pill and 66%
for the mini pill (p< .05). This significant difference in satis-
faction was also reflected in the comparison between SAC
and LARC methods (66% and 76%; p< .05).
Figure 2. Women’s awareness and self-reported knowledge of 14 contraceptive methods (n¼ 6027).
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Compliance with short acting contraceptive methods
Fifty per cent of all pill users (n¼ 2901) stated that they
had forgotten to take one or more of their pills in the last
three months. Of these, the majority (78%) had forgotten
to take them once or twice (see Figure 5). Women aged
<30 years tended to forget the pill more often than
women aged 30 years (54% versus 47%; p< .05). HCPs
generally underestimated the extent to which women for-
got to take their pill; believing that only 36% of women
had forgotten at least once in the last three months.
Use of emergency contraception
Thirty seven per cent of women included in the study had
used emergency contraception (EC) to prevent unintended
pregnancy at some point in their life. The majority of these
women (54%) had used it only once. HCPs generally under-
estimated the number of women who had used EC, believ-
ing on average that only 23% of women had ever used it
in their lifetime.
Needs and expectations regarding
contraceptive methods
When women were asked about the personal importance
of different attributes of a contraceptive (17 options were
presented; see Figure 6), assurance of reliability was identi-
fied as most important, rated as highly important (i.e., rated
as 6 or 7 on scale of 1–7) by 90% (mean score 6.6) of those
surveyed, irrespective of age or parity. A low risk of throm-
bosis was the second most important attribute, rated by
79% (mean score 6.2) of women as highly important. The
ability to fit to their lifestyle and suitability for individual
family planning were both rated as important by 72% of
women (mean score 5.9). Older women had different prior-
ities to younger or single women. For women aged 30
years, low risk of thrombosis, suitability for individual family
planning, freedom not to think about contraception con-
tinuously and a low dose of hormones were all significantly
more important than amongst younger women (aged
18–29 years). Both LARC and SAC users considered
(b)
(a)
Figure 3. (a) Methods used by women at the time of the survey (multiple answers were permitted), (n¼ 6027). (b) Methods used by women at the time of
the survey (multiple answers were permitted), in individual countries and grouped by method type (n¼ 6027). SAC methods include combined pill, mini-pill
(POP), vaginal ring, hormone injection and hormone patch; LARC methods include IUC (both IUD and hormonal IUD) and hormone implant.
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reliability, in terms of efficacy, to be the key attribute of a
contraceptive method. When looking at other important
attributes, low risk of thrombosis, fits to current lifestyle,
suits individual family planning, low dose of hormones,
suitable for nulliparous women, reduction in bleeding
intensity and pain and immediate reversibility on discon-
tinuation were all rated as highly important by 60% or
more of both LARC and SAC users.
Healthcare provider perception of the importance of
high reliability of a method to women matched the views
of those women surveyed. However, in contrast to women’s
views on the importance of safety, HCPs regarded
suitability with individual family planning, reduction of
bleeding intensity and pain during a period, fitting with
current lifestyle, fast return to fertility with cessation of use,
low dose of hormones and less monthly expense as the
most important attributes for women (see Figure 6).
Information needs: level of interest in receiving more
information about contraceptive methods
Sixty per cent of all women stated they would be inter-
ested in receiving more information (‘more frequent,
Figure 4. Women’s satisfaction with their current contraceptive methods rated on a scale of 1–7, where 1¼ not at all satisfied, and 7¼ very satisfied. Most
commonly used methods (by >2.5% of women surveyed) are presented.
Figure 5. Self-reported forgotten OC pills in the last three months amongst current OC-users surveyed (n¼ 2901).
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especially for new products’, or ‘more extensive’, or ‘more
frequent and more extensive’) about all contraceptive
methods from their HCP. There was a significant difference
in interest in receiving more information between SAC and
LARC users: almost two thirds (64%) of women currently
using a SAC method were interested in more information
compared to 51% of those using a LARC. Almost one-third
(29%) of all women were interested in hearing specifically
about new products. HCPs tended to underestimate wom-
en’s interest in receiving more regular or extensive informa-
tion (60%), declaring that only 46% of their patients would
be interested. There was also a mismatch regarding specific
interest in contraception with either no hormones or a low
dose of hormones: 62% of women were highly interested
in such contraceptives while HCPs believed that only 45%
of women would be highly interested (data not shown).
Information needs: interest in LARC
Seventy-three per cent of all women (n¼ 5564) stated that
LARCs could be a potential option if they were to receive
more information on the methods from their HCP. Women
who were aged 30–39 years or parous were significantly
more interested in LARCs as an option than women aged
18–29 and 40–49 years or nulliparous. However, only 28%
of women aged 18–29 years stated that a LARC method
would not be an option. As with interest in receiving more
information on all contraceptive methods, HCPs underesti-
mated women’s interest in LARCs as an option; on average,
believing only 38% of all women to be interested.
Evaluation of counselling
Women surveyed were generally more satisfied with staff
friendliness than other services relating to counselling qual-
ity (see Figure 7). Staff friendliness and quality of HCP con-
sultation on all contraceptive methods were rated as highly
satisfying (i.e., rated as 6 or 7 on scale of 1–7) by 83%
(mean score 6.3) and 73% (mean score 6.0) of women,
respectively. Although rating of consultation quality by
women was slightly lower than HCPs’ own rating (73% vs.
77%), views on the time available for a consultation were
more closely aligned.
Discussion
Findings and interpretation
The European TANCO study provides insights into contra-
ceptive use and satisfaction as well as knowledge of
Figure 6. Actual percentage of women rating attributes of contraception 6 or 7 (on a scale of 1–7 where 1¼ not important at all, and 7¼ very important) ver-
sus HCP estimations of importance of those attributes to women. Only attributes rated 6 or 7 by 60% of women are presented.
Figure 7. Women’s satisfaction with services relating to counselling versus HCP estimation of their patients’ satisfaction on a scale 1–7, where 1¼ insufficient/
poor and 7¼ very good.
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methods from 676 HCPs and 6027 women situated in
11 European countries. There was good awareness and
self-reported knowledge of SAC, natural and emergency
methods amongst the women surveyed; however, LARC
methods were less well-known. There was a high preva-
lence of contraceptive use across the 11 European coun-
tries and women of all ages were generally satisfied with
their current method. Almost half of all women were using
an OC and, even though the hormonal IUS was the second
most prevalent prescription method, it was used by only
one in ten women. LARC methods tended to be used by
older women (30 years) with children, a likely conse-
quence of previous recommendations for contraceptive
counselling. Approximately three quarters of the women
surveyed said they would consider LARCs as an option if
they received more comprehensive information.
Despite the paradigm shift around the use of LARCs,
many HCPs still believe that IUC is unsuitable for young or
nulliparous women and may limit counselling to only SAC
methods [15]. A move towards recommendations against
the use of COCs for women aged over 40 years and in
those with cardiovascular risk factors will focus HCP atten-
tion on recommending IUC for this age group [11,14]. In
addition, these women would not typically be planning to
have more children and so would be more interested in
using a LARC method.
Findings were generally consistent across the countries
and, where disparities existed, are likely to be explained by
differences in product availability and reimbursement sta-
tus. Use of LARC methods remains low despite recommen-
dations for broader use from global and national
organizations in countries with unreliable SAC users and
high abortion rates. This might reflect that many women
continue to choose OCs due to lack of knowledge of other
options or problems associated with reimbursement [6,20].
Factors such as the desire for good cycle control, a predict-
able bleeding pattern and improvement of menstrual
symptoms [21] may also continue to drive use of this
method, despite it being demonstrated in this and other
studies that correct daily pill intake is a challenge for some
women [18,20].
Satisfaction with current contraceptive method was gen-
erally high. Apart from users of combined pills, women
were generally more satisfied with their current methods
than expected by HCPs. High satisfaction rates are not sur-
prising given that dissatisfied women are likely to have
switched method earlier. The study findings show current
contraceptive use and related satisfaction; however, they
do not provide any insights regarding previous method use
and reasons for change. The greatest disparities between
women’s satisfaction and HCP perception was seen with
hormonal methods such as the patch, injection and
implant. For example, although 68% of women stated they
were highly satisfied with the hormonal implant, on aver-
age, HCPs estimated that only 22% would be satisfied.
HCPs clearly underestimated the interest in receiving
information about contraceptive methods in general. They
believed that just over a third of their patients (38%) would
be interested in using a LARC method, if they were to
receive more details, when almost double that number
(73%) of women stated this to be the case. Women also
had different views to their HCPs on what was important
regarding a method of contraception. Whilst both HCPs
and women were in agreement regarding the high import-
ance of ‘assurance of high reliability’ of contraceptive
method, our findings indicated that women were more
concerned with safety than HCPs realised. Women ranked
‘a low risk of thrombosis’ as the second most important
attribute of their contraceptive method. Given that the VTE
risk for healthy young COC users is low [21], greater clarifi-
cation of this risk to women expressing concern may be
needed during the consultation. On a broader basis, areas
of disconnect around women’s interest in receiving infor-
mation about different types of contraception and their
needs and expectations of methods demonstrate the need
for more effective communication and interaction between
HCPs and their patients.
Women and HCPs consistently rated the quality of con-
sultation on all suitable methods of contraception as highly
satisfying but knowledge (assessed by self-reported know-
ledge of all 14 methods) was low, suggesting that women
may have quickly discounted other methods as unsuitable
at some point in the counselling process or might be
unable to choose the most appropriate method for them
due to reimbursement policies.
Compliance rates with the pill highlighted many contra-
dictions. As with other studies comparing women’s use of
contraceptive methods, compliance amongst pill users was
poor. Although women reported high satisfaction with the
pill and regarded contraceptive reliability as very important,
the majority (77%) of women reporting they had missed a
pill said they had forgotten on one or two occasions in the
last three months. We know from studies such as CHOICE
that imperfect use of OCs contributes to a decrease in effi-
cacy as shown by the ‘typical use’ failure rate of 9% per
year [22,23].Any missed pills may therefore contribute to an
increased risk of unintended pregnancy and create uncer-
tainty for the women concerned. For the 12% of women
who reported they had forgotten more than three pills dur-
ing the last three months the risk of unintended pregnancy
is especially high [24].
Strengths and limitations of the study
A strength of the European TANCO study is the sample
size. We report the collected views of 6027 women across
11 countries. The study provides insights into factors that
women consider to be important when choosing contra-
ception and their interest in receiving more information
about other methods, all of which can guide HCPs in
addressing current unmet needs in contraceptive counsel-
ling. A further strength of the study is that the recruitment
process i.e., via HCP practices in the 11 countries, allowed
women’s views on many aspects of contraceptive use to be
compared with those of their respective HCPs.
A limitation of the European TANCO study is that all
respondents were self-selected by their willingness to
access a website and answer an online questionnaire.
Nineteen percent of women accessing the survey declined
to complete the questionnaire. Lack of an incentive was
thought to be the main reason for non-completion, how-
ever, this information was not captured formally.
Only women visiting a HCP were included. The lack of
information about reason for the visit, absence of recruit-
ment quotas and wide variation (no weighting) in the
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number of participants means that findings are unlikely to
be wholly representative of contraceptive users or their
HCPs in each country and valid cross-country comparison
regarding attitudes or beliefs amongst sub-groups was diffi-
cult to achieve.
Levels of self-reported knowledge of contraceptive
methods were low in the European TANCO study. As a
short, online survey, it was difficult to correlate this self-
reported knowledge with actual knowledge of different
methods. As with the European CHOICE study [25], which
assessed women’s perceptions and reasons for choosing
one of three particular methods (the pill, patch or ring), our
survey showed that women reported greater knowledge of
methods they were using or had used than those
never used.
Although it was useful to evaluate the extent to which
women were satisfied with their current method of contra-
ception, a further limitation of an online survey such as the
European TANCO study was the absence of questions
about the features of a method women were satisfied with
and also reasons for dissatisfaction with previous methods.
The study included over 6000 women, However, the
minimum age excluded the participation of many adoles-
cent women (those aged <18 years). This group of women
were identified by the European CHOICE study as being
greatly influenced by balanced counselling from their HCP
[26]. Analysis of the 15–20-year-old sub-group found that
counselling on methods such as the combined OC, patch
and ring greatly influenced decisions on which method to
choose and led to broader use of the patch and the ring
by this age group [26].
We know from a survey by Gemzell-Danielsson et al.
[27] that age, gender, type of HCP and personal experience
of contraceptive methods all influence the extent to which
some methods (such as the pill and IUC) are discussed
within a consultation. The majority of HCPs participating in
the European TANCO study were gynaecologists (87%) and
female (63%) and we have no knowledge of their personal
(or partner) experience of contraceptive methods.
Healthcare provider influence on the knowledge and use of
contraceptive methods by women participating in the
study could therefore be an additional limitation.
Comparison with other studies
The findings of the European TANCO study reflect those of
other studies investigating women’s needs and expecta-
tions of contraception and their information requirements
conducted on a national or global basis [20,28]. An inter-
national study of 12,094 women across Brazil, Europe, and
the US reported a high level of combined OC use, high sat-
isfaction (73%) with current methods, the importance of
contraceptive reliability and a high rate of noncompliance
amongst OC users [20]. High use of combined OCs, high
satisfaction levels and importance of reliability were also
reported in a quantitative study of knowledge and use of
contraceptive methods amongst 2544 women in the US,
UK, Germany, Italy, and Spain [28].
When asking women about their needs and expectations
of contraception, importance of predictability of bleeding
were not included as potential factors in the European
TANCO study. Several studies across different countries
indicate the negative attitudes of women towards break-
through bleeding and unpredictable bleeding, the most fre-
quent reason for discontinuation of progestin-only pills and
implants [20,29,30]. On the one hand, we know from the
study by Mansour et al. [20] that many women (49%)
regard the absence of a monthly period as unhealthy or
see its presence as confirmation that they are not pregnant.
However, in a global, population-based study focused spe-
cifically on attitudes towards monthly bleeding [29], almost
one-third said that bleeding had a negative impact on
quality of life, 60% of women said they would like to be
able to delay their bleeding and approximately one third
said they would prefer to bleed less frequently i.e., once in
every two or three months. These findings were also
reflected in a survey of Swiss women’s preferred menstrual/
withdrawal bleeding pattern over their reproductive life.
Amongst almost 300 women aged between 15 and 49
years, 32% stated they would prefer to bleed every two to
six months and a further 29% said they would prefer not
to bleed at all [30].
The high awareness and use of OCs demonstrated in
this study reflects the findings of other studies [20,28]. The
above quantitative study of 2544 women in Europe and
the US [28] found that women aged 25–44 were aware of a
wide variety of contraceptive methods, but knowledge and
usage of the pill and condoms dominated. Similarly, the
international study assessing women’s attitudes to daily
contraceptive use [20] reported reasonable awareness of
contraceptive methods, with a high level of pill use and a
high level of satisfaction with its use. Use of LARC methods
was low (8.5%); fears about pain (with IUC), fear of being
able to feel an implant or concerns about efficacy cited as
concerns by over a third of women [20].
The high level of interest in information about LARC
methods reflects the findings of the US Contraceptive
CHOICE study, where 75% of study participants chose one
of three LARC methods when provided with information on
all contraceptive choices and methods were provided free
of charge [10]. Healthcare provider beliefs about lack of
interest may limit the extent to which they share informa-
tion about all contraceptive methods and artificially limit
use of LARCs [13]. The Contraceptive Use, Pregnancy
Intentions and Decisions (CUPID) study of 3795 Australian
women aged 18–23 years observed that women required
consistent and accurate information that extended beyond
OCs and often felt frustrated by the choice limitations
imposed by their HCPs, particularly when they were seen
to be linked to their age [31].
The findings of the European TANCO study regarding
satisfaction with the time and quality of contraceptive
counselling contrast markedly with those of other studies
which describe complaints by women about lack of time
available to express their needs, lack of comprehensive
information and a tendency towards provider–dominated
interactions that fail to allow for women’s involvement
[32–35]. This discrepancy could be due to the design of the
study; although anonymity was guaranteed, the women
were recruited via their HCP and therefore were potentially
prone to a social desirability or loyalty bias. However, this
methodology was necessary to allow effective comparisons.
The possibility of a loyalty bias is also supported by the
apparent contradiction between satisfaction with counsel-
ling and the high levels of women’s interest in receiving
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further information about other contraceptive methods,
including LARCs, a finding that is consistent with that
reported by the US CHOICE study [10].
Open questions and future research
Although valuable, the findings from this study point to
larger, unanswered questions around the impact of social
media and internet sources on women’s knowledge and
use of contraception. Closer analysis of the larger sub-
groups, such as nulliparous women, may also provide some
useful data to compare with other studies on contraceptive
use by this population.
Conclusions
The European TANCO study found contraceptive use to be
generally high amongst women. However, awareness of a
broader range of methods was lacking. The majority of
women across Europe were using OCs; only 18% were
using a LARC method. Despite high levels of satisfaction
with current methods, women were interested in receiving
more information about all contraceptive methods. This
represents a good opportunity for HCPs to discuss use of
LARCs, especially as our study showed only limited know-
ledge of these methods amongst respondents. When
choosing a contraceptive method, women regarded reliabil-
ity and safety as the two most important attributes. Greater
exploration of women’s feelings regarding their needs and
expectations of contraception could lead to expansion of
knowledge, more effective discussions and greater likeli-
hood of informed contraceptive choice for women. This will
translate into higher satisfaction and continuation rates
and, ultimately, may contribute to a decrease in the rate of
unintended pregnancies.
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